CME Group Inc. Reports First-Quarter 2022 Financial Results
The company reported revenue of
"During this period of extreme geopolitical and economic uncertainty, our continued focus on helping clients manage their risk resulted in strong earnings and revenue growth during the first quarter," said
First-quarter 2022 average daily volume (ADV) was 25.9 million contracts, including non-
1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials. |
Clearing and transaction fees revenue for first-quarter 2022 totaled
As of
As the world's leading derivatives marketplace,
Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services, including our ability to provide effective services to the swaps market; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by our third-party providers; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, credit spreads, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; the impact of the COVID-19 pandemic and response by governments and other third parties; our ability to accommodate increases in contract volume and order transaction traffic and to implement enhancements without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including those associated with our joint venture with IHS Markit and our partnership with
|
||||
Consolidated Balance Sheets |
||||
(in millions) |
||||
|
|
|||
ASSETS |
||||
Current Assets: |
||||
Cash and cash equivalents |
$ 2,045.7 |
$ 2,834.9 |
||
Marketable securities |
109.6 |
115.0 |
||
Accounts receivable, net of allowance |
608.9 |
434.5 |
||
Other current assets (includes |
503.4 |
427.8 |
||
Performance bonds and guaranty fund contributions |
167,736.7 |
157,949.6 |
||
Total current assets |
171,004.3 |
161,761.8 |
||
Property, net of accumulated depreciation and amortization |
493.9 |
505.3 |
||
Intangible assets—trading products |
17,175.3 |
17,175.3 |
||
Intangible assets—other, net |
3,463.2 |
3,532.0 |
||
|
10,515.8 |
10,528.0 |
||
Other assets (includes |
3,265.2 |
3,277.9 |
||
Total Assets |
$ 205,917.7 |
$ 196,780.3 |
||
LIABILITIES AND EQUITY |
||||
Current Liabilities: |
||||
Accounts payable |
$ 80.8 |
$ 48.8 |
||
Short-term debt |
— |
749.4 |
||
Other current liabilities |
641.1 |
1,650.6 |
||
Performance bonds and guaranty fund contributions |
167,736.7 |
157,949.6 |
||
Total current liabilities |
168,458.6 |
160,398.4 |
||
Long-term debt |
3,437.1 |
2,695.7 |
||
Deferred income tax liabilities, net |
5,381.7 |
5,390.4 |
||
Other liabilities |
903.5 |
896.5 |
||
Total Liabilities |
178,180.9 |
169,381.0 |
||
Total CME Group Shareholders' Equity |
27,736.8 |
27,399.3 |
||
Total Liabilities and Equity |
$ 205,917.7 |
$ 196,780.3 |
|
||||
Consolidated Statements of Income |
||||
(dollars in millions, except per share amounts; shares in thousands) |
||||
Quarter Ended |
||||
2022 |
2021 |
|||
Revenues |
||||
Clearing and transaction fees |
$ 1,138.1 |
$ 1,007.0 |
||
Market data and information services |
151.7 |
144.2 |
||
Other |
56.8 |
102.1 |
||
Total Revenues |
1,346.6 |
1,253.3 |
||
Expenses |
||||
Compensation and benefits |
185.2 |
225.0 |
||
Technology |
45.9 |
48.2 |
||
Professional fees and outside services |
31.8 |
37.4 |
||
Amortization of purchased intangibles |
58.4 |
60.6 |
||
Depreciation and amortization |
33.5 |
37.6 |
||
Licensing and other fee agreements |
80.9 |
64.7 |
||
Other |
51.8 |
54.7 |
||
Total Expenses |
487.5 |
528.2 |
||
Operating Income |
859.1 |
725.1 |
||
Non-Operating Income (Expense) |
||||
Investment income |
73.1 |
30.9 |
||
Interest and other borrowing costs |
(42.5) |
(41.5) |
||
Equity in net earnings of unconsolidated subsidiaries |
73.3 |
56.2 |
||
Other non-operating income (expense) |
(46.7) |
(18.4) |
||
Total Non-Operating Income (Expense) |
57.2 |
27.2 |
||
Income before Income Taxes |
916.3 |
752.3 |
||
Income tax provision |
205.3 |
177.5 |
||
Net Income |
711.0 |
574.8 |
||
Less: net (income) loss attributable to non-controlling interests |
— |
(0.4) |
||
Net Income Attributable to |
$ 711.0 |
$ 574.4 |
||
Net Income Attributable to Common Shareholders of |
$ 702.0 |
$ 574.4 |
||
Earnings per Share Attributable to Common Shareholders of |
||||
Basic |
$ 1.96 |
$ 1.60 |
||
Diluted |
1.95 |
1.60 |
||
Weighted Average Number of Common Shares: |
||||
Basic |
358,609 |
358,147 |
||
Diluted |
359,180 |
358,817 |
|
||||||||||
Quarterly Operating Statistics |
||||||||||
1Q 2021 |
2Q 2021 |
3Q 2021 |
4Q 2021 |
1Q 2022 |
||||||
Trading Days |
61 |
63 |
64 |
64 |
62 |
Quarterly Average Daily Volume (ADV)(1) |
||||||||||
CME Group ADV (in thousands) |
||||||||||
Product Line |
1Q 2021 |
2Q 2021 |
3Q 2021 |
4Q 2021 |
1Q 2022 |
|||||
Interest rates |
10,349 |
8,581 |
8,111 |
9,805 |
12,484 |
|||||
Equity indexes |
6,117 |
4,926 |
5,100 |
5,943 |
7,950 |
|||||
Foreign exchange |
852 |
769 |
776 |
800 |
904 |
|||||
Energy |
2,363 |
1,963 |
2,179 |
2,252 |
2,515 |
|||||
Agricultural commodities |
1,471 |
1,631 |
1,141 |
1,216 |
1,474 |
|||||
Metals |
675 |
568 |
480 |
475 |
593 |
|||||
Total |
21,827 |
18,438 |
17,786 |
20,490 |
25,920 |
|||||
Venue |
||||||||||
CME Globex |
20,436 |
17,223 |
16,652 |
19,043 |
24,060 |
|||||
Open outcry |
678 |
646 |
598 |
792 |
1,030 |
|||||
Privately negotiated |
713 |
569 |
536 |
656 |
830 |
|||||
Total |
21,827 |
18,438 |
17,786 |
20,490 |
25,920 |
Quarterly Average Rate Per Contract (RPC)(1) |
||||||||||
CME Group RPC |
||||||||||
Product Line |
1Q 2021 |
2Q 2021 |
3Q 2021 |
4Q 2021 |
1Q 2022 |
|||||
Interest rates |
$ 0.475 |
$ 0.491 |
$ 0.483 |
$ 0.487 |
$ 0.484 |
|||||
Equity indexes |
0.532 |
0.555 |
0.555 |
0.526 |
0.526 |
|||||
Foreign exchange |
0.779 |
0.805 |
0.803 |
0.779 |
0.800 |
|||||
Energy |
1.097 |
1.140 |
1.127 |
1.111 |
1.124 |
|||||
Agricultural commodities |
1.343 |
1.343 |
1.319 |
1.323 |
1.378 |
|||||
Metals |
1.415 |
1.438 |
1.463 |
1.452 |
1.482 |
|||||
Average RPC |
$ 0.658 |
$ 0.695 |
$ 0.677 |
$ 0.650 |
$ 0.644 |
|||||
1. ADV and RPC includes futures and options on futures only. |
|
||||
Reconciliation of GAAP to non-GAAP Measures |
||||
(dollars in millions, except per share amounts; shares in thousands) |
||||
Quarter Ended |
||||
2022 |
2021 |
|||
Net Income Attributable to |
$ 711.0 |
$ 574.4 |
||
Restructuring and severance |
3.7 |
14.8 |
||
Amortization of purchased intangibles(1) |
69.8 |
60.6 |
||
Strategic transaction-related costs(2) |
1.6 |
10.2 |
||
Foreign exchange transaction (gains) losses |
(4.3) |
2.4 |
||
Unrealized and realized gains on investments |
(4.0) |
(1.3) |
||
Debt costs related to refinancing |
7.7 |
— |
||
Realized and unrealized losses on assets |
— |
0.8 |
||
Trading floor enhancements |
4.4 |
— |
||
Income tax effect related to above |
(15.8) |
(20.7) |
||
Other income tax items(3) |
(7.9) |
— |
||
Adjusted Net Income Attributable to |
$ 766.2 |
$ 641.2 |
||
Adjusted Net Income Attributable to Common Shareholders of |
$ 756.6 |
$ 641.2 |
||
Earnings per Share Attributable to Common Shareholders of |
||||
Basic |
$ 1.96 |
$ 1.60 |
||
Diluted |
1.95 |
1.60 |
||
Adjusted Earnings per Share Attributable to Common Shareholders of |
||||
Basic |
$ 2.11 |
$ 1.79 |
||
Diluted |
2.11 |
1.79 |
||
Weighted Average Number of Common Shares: |
||||
Basic |
358,609 |
358,147 |
||
Diluted |
359,180 |
358,817 |
||
Preferred shares(4) |
4,584 |
— |
||
1. Includes |
||||
2. Strategic transaction-related costs primarily include professional fees related to the NEX integration. |
||||
3. Other income tax items include benefits recognized for the settlement of various tax audits. |
||||
4. Preferred shares have similar rights as common shares without voting rights. |
Media contact |
Investor contact |
|
|
|
|
CME-G
View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-first-quarter-2022-financial-results-301533710.html
SOURCE CME Group